[
    {
        "id": "bowtie_blood_hyperhemolysis_v2026_82",
        "type": "bowtie",
        "stem": "A client with sickle cell disease (SCD) received 2 units of packed red blood cells (PRBCs) for severe anemia 5 days ago. The client now returns with a hemoglobin level LOWER than before the transfusion. Based on the documentation, complete the bowtie by selecting the most likely condition, the two actions the nurse should take, and the two parameters the nurse should monitor.",
        "itemContext": {
            "tabs": [
                {
                    "id": "sbar",
                    "title": "SBAR",
                    "content": "<b>Situation:</b> The client is experiencing a paradoxical drop in hemoglobin following a blood transfusion. The client is also febrile and profoundly weak.<br><br><b>Background:</b> The client has a history of HbSS sickle cell disease. Pre-transfusion hemoglobin was 6.2 g/dL, and the client received 2 units of packed red blood cells.<br><br><b>Assessment:</b> Current hemoglobin is critically low at 4.8 g/dL. The reticulocyte count is suppressed at 1%. Urine is dark, consistent with hemoglobinuria. Indirect bilirubin is elevated at 8.4 mg/dL. Vital signs include BP 90/58 mmHg, HR 132 bpm, RR 26 breaths/min, and T 102.4째F (39.1째C).<br><br><b>Recommendation:</b> Avoid further blood transfusions. Consider IVIG or high-dose corticosteroids. Monitor hemoglobin levels, reticulocyte count, and urine output closely. Notify the blood bank immediately."
                },
                {
                    "id": "hematology",
                    "title": "Hematology & Transfusion Log",
                    "content": "<table><thead><tr><th>Test Item</th><th>Baseline (Pre-Transfusion)</th><th>Today (Post-Transfusion)</th></tr></thead><tbody><tr><td>Hemoglobin (Hgb)</td><td>6.2 g/dL</td><td>4.8 g/dL (Critical Drop)</td></tr><tr><td>Reticulocyte Count</td><td>12%</td><td>1% (Suppressed)</td></tr><tr><td>Urine Color</td><td>Amber</td><td>Dark/Black (Cola)</td></tr><tr><td>Indirect Bilirubin</td><td>2.2 mg/dL</td><td>8.4 mg/dL (Massive Hemolysis)</td></tr></tbody></table>"
                },
                {
                    "id": "vitals",
                    "title": "Vital Signs",
                    "content": "BP 90/58 mmHg, HR 132 bpm, RR 26 breaths/min, T 102.4째F (39.1째C). Client is profoundly weak."
                },
                {
                    "id": "radiology",
                    "title": "Radiology",
                    "content": "No radiology reports available."
                },
                {
                    "id": "mar",
                    "title": "MAR",
                    "content": "No medications were administered since the last blood transfusion."
                }
            ]
        },
        "bowtieData": {
            "conditionOptions": [
                {
                    "id": "c1",
                    "text": "Delayed Hemolytic Transfusion Reaction (DHTR)"
                },
                {
                    "id": "c2",
                    "text": "Hyperhemolysis Syndrome (HHS)"
                },
                {
                    "id": "c3",
                    "text": "Iron Overload (Transfusional Hemosiderosis)"
                }
            ],
            "actionOptions": [
                {
                    "id": "a1",
                    "text": "Avoid further blood transfusions, as they will worsen the hemolysis."
                },
                {
                    "id": "a2",
                    "text": "Prepare to administer IVIG or high-dose corticosteroids."
                },
                {
                    "id": "a3",
                    "text": "Increase the IV rate of blood to 150 mL/hr to rescue the Hgb."
                },
                {
                    "id": "a4",
                    "text": "Encourage the client to drink iron-fortified juices."
                }
            ],
            "parameterOptions": [
                {
                    "id": "p1",
                    "text": "Hemoglobin (Hgb) levels and reticulocyte count trends."
                },
                {
                    "id": "p2",
                    "text": "Urine color and presence of hemoglobinuria (cola-colored urine)."
                },
                {
                    "id": "p3",
                    "text": "Daily measurement of fasting serum glucose."
                },
                {
                    "id": "p4",
                    "text": "Presence of a positive Trousseau sign."
                }
            ]
        },
        "correctAnswers": {
            "condition": "c2",
            "actions": [
                "a1",
                "a2"
            ],
            "parameters": [
                "p1",
                "p2"
            ]
        },
        "pedagogy": {
            "bloomLevel": "analyze",
            "cjmmStep": "takeAction",
            "nclexCategory": "Physiological Adaptation",
            "difficulty": 4,
            "topicTags": [
                "Hyperhemolysis",
                "Sickle Cell Disease",
                "Blood Transfusion"
            ]
        },
        "rationale": {
            "correct": "The client is experiencing Hyperhemolysis Syndrome (HHS) (c2), a life-threatening complication post-transfusion in SCD patients. In HHS, the body destroys both the transfused donor cells and the patient's own native cells, leading to a paradoxical drop in hemoglobin *below* the pre-transfusion baseline (from 6.2 g/dL to 4.8 g/dL). The suppressed reticulocyte count (1%) despite the severe anemia is another key indicator. The priority nursing actions are to avoid further blood transfusions (a1), as this will exacerbate the hemolysis, and to prepare for immunosuppression with IVIG or high-dose corticosteroids (a2) to halt the destructive process. Monitoring hemoglobin levels and reticulocyte count trends (p1) is crucial to assess the response to treatment. Additionally, monitoring urine color and the presence of hemoglobinuria (cola-colored urine) (p2) helps to track ongoing hemolysis.",
            "clinicalPearls": [
                "In Hyperhemolysis Syndrome (HHS), the hemoglobin drops, the reticulocyte count drops paradoxically, and the bilirubin spikes.",
                "HHS is one of the few anemia emergencies where the answer is 'DO NOT GIVE BLOOD.'",
                "Always notify the blood bank immediately if a patient develops severe anemia following a transfusion."
            ],
            "questionTrap": {
                "trap": "The low hemoglobin level of 4.8 g/dL may lead to the incorrect assumption that the client needs more blood.",
                "howToOvercome": "In SCD, if the hemoglobin is lower than the starting point *after* a transfusion, further transfusions are detrimental. Instead, focus on immunosuppression with IVIG or corticosteroids to stop the hyperhemolysis."
            },
            "mnemonic": {
                "title": "Hyper-Hemi",
                "expansion": "H-Hgb drops lower. H-Heat (Fever). H-Halt blood transfusions! H-High-dose steroids."
            }
        },
        "scoring": {
            "method": "polytomous",
            "maxPoints": 5
        },
        "sentinelStatus": "healed_v2026_v11"
    }
]